New Key Statistics Module, Z-Score and F-Score
NAS:ALZN Key Ratios
Market Cap $ M | 6.14 |
Enterprise Value $ M | 6.06 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.58 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -6.69 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -106.60 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.04 |
EV-to-EBITDA | -1.05 |
PEG | -- |
Shares Outstanding M | 5.43 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 3.80 |
Current Ratio | 3.80 |
ROA % (ttm) | -322.24 |
ROE % (ttm) | -- |
ROIC % (ttm) | -2,137.10 |
Dividend Yield % | -- |
Altman Z-Score | -- |
ALZN Number of Guru Trades
ALZN Volume of Guru Trades
Gurus Latest Trades with NAS:ALZN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ALZN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Alzamend Neuro Inc Insider Transactions
No Available Data
News about NAS:ALZN
Total 0- 1